Organoid Cultures Derived from Patients with Advanced Prostate CancerDong Gao, Yu Chen, Ian Vela et al.|Cell|2014Cited by 1.6k
NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.Edward M. Schaeffer, Deborah A. Freedman-Cass, Heather H. Cheng et al.|PubMed|2022Cited by 172
Impact of Therapy on Genomics and Transcriptomics in High-Risk Prostate Cancer Treated with Neoadjuvant Docetaxel and Androgen Deprivation TherapyHimisha Beltran, Martin Gleave, Alexander W. Wyatt et al.|Clinical Cancer Research|2017Cited by 75
Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trialTakayuki Sumiyoshi, Himisha Beltran, Xiaofei Wang et al.|JNCI Journal of the National Cancer Institute|2023Cited by 9